Search

Your search keyword '"Cardoso-Landivar, J"' showing total 8 results
Start Over Author "Cardoso-Landivar, J"
8 results on '"Cardoso-Landivar, J"'

1. Tuberculosis and COVID-19 co-infection: description of the global cohort

Author

Casco, N, Jorge, AL, Palmero, DJ, Alffenaar, J-W, Denholm, J, Fox, GJ, Ezz, W, Cho, J-G, Skrahina, A, Solodovnikova, V, Bachez, P, Piubello, A, Arbex, MA, Alves, T, Rabahi, MF, Pereira, GR, Sales, R, Silva, DR, Saffie, MM, Miranda, RC, Cancino, V, Carbonell, M, Cisterna, C, Concha, C, Cruz, A, Salinas, NE, Revillot, ME, Valdes, JF, Fernandez, I, Flores, X, Tapia, PG, Garavagno, A, Vera, CG, Bahamondes, MH, Merino, LM, Munoz, E, Munoz, C, Navarro, I, Subiabre, JN, Ortega, C, Palma, S, Pradenas, AM, Pereira, G, Castillo, PP, Pinto, M, Pizarro, R, Bidegain, FR, Rodriguez, P, Sanchez, C, Salinas, AS, Soto, A, Taiba, C, Venegas, M, Riquelme, MSV, Vilca, E, Villalon, C, Yucra, E, Li, Y, Guelvez, B, Plaza, RV, Hoyos, KYT, Andrejak, C, Blanc, F-X, Dourmane, S, Froissart, A, Izadifar, A, Riviere, F, Schlemmer, F, Manika, K, Diallo, BD, Hassane-Harouna, S, Artiles, N, Mejia, LA, Gupta, N, Ish, P, Mishra, G, Sharma, S, Singla, R, Udwadia, ZF, Alladio, F, Angeli, F, Calcagno, A, Centis, R, Codecasa, LR, D'Ambrosio, L, Lauretis, AD, Esposito, S, Formenti, B, Gaviraghi, A, Giacomet, V, Goletti, D, Gualano, G, Matteelli, A, Migliori, GB, Motta, I, Palmieri, F, Pontali, E, Prestileo, T, Riccardi, N, Saderi, L, Saporiti, M, Sotgiu, G, Stochino, C, Tadolini, M, Torre, A, Villa, S, Visca, D, Danila, E, Diktanas, S, Ridaura, RL, Lopez, FLL, Torrico, MM, Rendon, A, Akkerman, OW, Souleymane, MB, Al-Abri, S, Alyaquobi, F, Althohli, K, Aizpurua, E, Gonzales, R, Jurado, J, Loban, A, Aguirre, S, Teixeira, RC, De Egea, V, Irala, S, Medina, A, Sequera, G, Sosa, N, Vazquez, F, Llanos-Tejada, FK, Manga, S, Villanueva-Villegas, R, Araujo, D, Duarte, R, Marques, TS, Grecu, VI, Socaci, A, Barkanova, O, Bogorodskaya, M, Borisov, S, Mariandyshev, A, Kaluzhenina, A, Vukicevic, TA, Stosic, M, Beh, D, Ng, D, Ong, CWM, Solovic, I, Dheda, K, Gina, P, Caminero, JA, Cardoso-Landivar, J, Galvao, MLDS, Dominguez-Castellano, A, Garcia-Garcia, J-M, Pinargote, IM, Fernandez, SQ, Sanchez-Montalva, A, Huguet, ET, Murguiondo, MZ, Bart, P-A, Mazza-Stalder, J, Bakko, F, Barnacle, J, Brown, A, Chandran, S, Killington, K, Man, K, Papineni, P, Tiberi, S, Utjesanovic, N, Zenner, D, Hearn, JL, Heysell, S, Young, L, Casco, N, Jorge, AL, Palmero, DJ, Alffenaar, J-W, Denholm, J, Fox, GJ, Ezz, W, Cho, J-G, Skrahina, A, Solodovnikova, V, Bachez, P, Piubello, A, Arbex, MA, Alves, T, Rabahi, MF, Pereira, GR, Sales, R, Silva, DR, Saffie, MM, Miranda, RC, Cancino, V, Carbonell, M, Cisterna, C, Concha, C, Cruz, A, Salinas, NE, Revillot, ME, Valdes, JF, Fernandez, I, Flores, X, Tapia, PG, Garavagno, A, Vera, CG, Bahamondes, MH, Merino, LM, Munoz, E, Munoz, C, Navarro, I, Subiabre, JN, Ortega, C, Palma, S, Pradenas, AM, Pereira, G, Castillo, PP, Pinto, M, Pizarro, R, Bidegain, FR, Rodriguez, P, Sanchez, C, Salinas, AS, Soto, A, Taiba, C, Venegas, M, Riquelme, MSV, Vilca, E, Villalon, C, Yucra, E, Li, Y, Guelvez, B, Plaza, RV, Hoyos, KYT, Andrejak, C, Blanc, F-X, Dourmane, S, Froissart, A, Izadifar, A, Riviere, F, Schlemmer, F, Manika, K, Diallo, BD, Hassane-Harouna, S, Artiles, N, Mejia, LA, Gupta, N, Ish, P, Mishra, G, Sharma, S, Singla, R, Udwadia, ZF, Alladio, F, Angeli, F, Calcagno, A, Centis, R, Codecasa, LR, D'Ambrosio, L, Lauretis, AD, Esposito, S, Formenti, B, Gaviraghi, A, Giacomet, V, Goletti, D, Gualano, G, Matteelli, A, Migliori, GB, Motta, I, Palmieri, F, Pontali, E, Prestileo, T, Riccardi, N, Saderi, L, Saporiti, M, Sotgiu, G, Stochino, C, Tadolini, M, Torre, A, Villa, S, Visca, D, Danila, E, Diktanas, S, Ridaura, RL, Lopez, FLL, Torrico, MM, Rendon, A, Akkerman, OW, Souleymane, MB, Al-Abri, S, Alyaquobi, F, Althohli, K, Aizpurua, E, Gonzales, R, Jurado, J, Loban, A, Aguirre, S, Teixeira, RC, De Egea, V, Irala, S, Medina, A, Sequera, G, Sosa, N, Vazquez, F, Llanos-Tejada, FK, Manga, S, Villanueva-Villegas, R, Araujo, D, Duarte, R, Marques, TS, Grecu, VI, Socaci, A, Barkanova, O, Bogorodskaya, M, Borisov, S, Mariandyshev, A, Kaluzhenina, A, Vukicevic, TA, Stosic, M, Beh, D, Ng, D, Ong, CWM, Solovic, I, Dheda, K, Gina, P, Caminero, JA, Cardoso-Landivar, J, Galvao, MLDS, Dominguez-Castellano, A, Garcia-Garcia, J-M, Pinargote, IM, Fernandez, SQ, Sanchez-Montalva, A, Huguet, ET, Murguiondo, MZ, Bart, P-A, Mazza-Stalder, J, Bakko, F, Barnacle, J, Brown, A, Chandran, S, Killington, K, Man, K, Papineni, P, Tiberi, S, Utjesanovic, N, Zenner, D, Hearn, JL, Heysell, S, and Young, L more...

Abstract

BACKGROUND: Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes. METHODS: We enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based). RESULTS: Of 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality. CONCLUSION: The data suggest that TB and COVID-19 are a "cursed duet" and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination. more...

Published
2022

2. Tuberculosis and COVID-19 co-infection: description of the global cohort

Author

Migliori, G. B., Casco, N., Jorge, A. L., Palmero, D. J., Alffenaar, J. -W., Denholm, J., Fox, G. J., Ezz, W., Cho, J. -G., Skrahina, A., Solodovnikova, V., Bachez, P., Piubello, A., Arbex, M. A., Alves, T., Rabahi, M. F., Pereira, G. R., Sales, R., Silva, D. R., Saffie, M. M., Miranda, R. C., Cancino, V., Carbonell, M., Cisterna, C., Concha, C., Cruz, A., Salinas, N. E., Revillot, M. E., Valdes, J. F., Fernandez, I., Flores, X., Tapia, P. G., Garavagno, A., Vera, C. G., Bahamondes, M. H., Merino, L. M., Munoz, E., Munoz, C., Navarro, I., Subiabre, J. N., Ortega, C., Palma, S., Pradenas, A. M., Pereira, G., Castillo, P. P., Pinto, M., Pizarro, R., Bidegain, F. R., Rodriguez, P., Sanchez, C., Salinas, A. S., Soto, A., Taiba, C., Venegas, M., Riquelme, M. S. V., Vilca, E., Villalon, C., Yucra, E., Li, Y., Guelvez, B., Plaza, R. V., Hoyos, K. Y. T., Andrejak, C., Blanc, F. -X., Dourmane, S., Froissart, A., Izadifar, A., Riviere, F., Schlemmer, F., Manika, K., Diallo, B. D., Hassane-Harouna, S., Artiles, N., Mejia, L. A., Gupta, N., Ish, P., Mishra, G., Sharma, S., Singla, R., Udwadia, Z. F., Alladio, F., Angeli, F., Calcagno, A., Centis, R., Codecasa, L. R., D'Ambrosio, L., De Lauretis, A., Esposito, S., Formenti, B., Gaviraghi, A., Giacomet, V., Goletti, D., Gualano, G., Matteelli, A., Motta, I., Palmieri, F., Pontali, E., Prestileo, T., Riccardi, N., Saderi, L., Saporiti, M., Sotgiu, G., Stochino, C., Tadolini, M., Torre, A., Villa, S., Visca, D., Danila, E., Diktanas, S., Ridaura, R. L., Lopez, F. L. L., Torrico, M. M., Rendon, A., Akkerman, O. W., Souleymane, M. B., Al-Abri, S., Alyaquobi, F., Althohli, K., Aizpurua, E., Gonzales, R., Jurado, J., Loban, A., Aguirre, S., Teixeira, R. C., De Egea, V., Irala, S., Medina, A., Sequera, G., Sosa, N., Vazquez, F., Llanos-Tejada, F. K., Manga, S., Villanueva-Villegas, R., Araujo, D., Duarte, R., Marques, T. S., Grecu, V. I., Socaci, A., Barkanova, O., Bogorodskaya, M., Borisov, S., Mariandyshev, A., Kaluzhenina, A., Vukicevic, T. A., Stosic, M., Beh, D., Ng, D., Ong, C. W. M., Solovic, I., Dheda, K., Gina, P., Caminero, J. A., Cardoso-Landivar, J., De Souza Galvao, M. L., Dominguez-Castellano, A., Garcia-Garcia, J. -M., Pinargote, I. M., Fernandez, S. Q., Sanchez-Montalva, A., Huguet, E. T., Murguiondo, M. Z., Bart, P. -A., Mazza-Stalder, J., Bakko, F., Barnacle, J., Brown, A., Chandran, S., Killington, K., Man, K., Papineni, P., Tiberi, S., Utjesanovic, N., Zenner, D., Hearn, J. L., Heysell, S., and Young, L. more...

Subjects
Pulmonary and Respiratory Medicine, Cohort Studies, Male, Coinfection, Humans, Prospective Studies, COVID-19, Tuberculosis, Original Research Article
Abstract

BackgroundInformation on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes.MethodsWe enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based).ResultsOf 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality.ConclusionThe data suggest that TB and COVID-19 are a “cursed duet” and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination. more...

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results

3. TB and COVID-19 co-infection: rationale and aims of a global study

Author

Casco, N., Jorge, A. L., Palmero, D., Alffenaar, J. -W., Fox, G., Ezz, W., Cho, J. -G., Skrahina, A., Solodovnikova, V., Bachez, P., Arbex, M. A., Galvao, T., Rabahi, M., Pereira, G. R., Sales, R., Silva, D. R., Saffie, M. M., Miranda, R. C., Cancino, V., Carbonell, M., Cisterna, C., Concha, C., Cruz, A., Salinas, N. E., Revillot, M. E., Farias, J., Fernandez, I., Flores, X., Gallegos, P., Garavagno, A., Guajardo, C., Bahamondes, M. H., Merino, L. M., Munoz, E., Munoz, C., Navarro, I., Navarro, J., Ortega, C., Palma, S., Pardenas, A. M., Pereira, G., Castillo, P. P., Pinto, M., Pizarro, R., Rivas, F., Rodriguez, P., Sanchez, C., Serrano, A., Soto, A., Taiba, C., Venegas, M., Vergara, M. S., Vilca, E., Villalon, C., Yucra, E., Li, Y., Guelvez, B., Plaza, R., Tello, K., Andrejak, C., Blanc, F. -X., Dourmane, S., Froissart, A., Izadifar, A., Riviere, F., Schlemmer, F., Gupta, N., Ish, P., Mishra, G., Sharma, S., Singla, R., Udwadia, Z. F., Manika, K., Diallo, B. D., Hassane-Harouna, S., Artiles, N., Mejia, L. A., Alladio, F., Calcagno, A., Centis, R., Codecasa, L. R., D'Ambrosio, L., Formenti, B., Gaviraghi, A., Giacomet, V., Goletti, D., Gualano, G., Matteelli, A., Migliori, G. B., Motta, I., Palmieri, F., Prestileo, T., Riccardi, N., Saderi, L., Saporiti, M., Sotgiu, G., Stochino, C., Tadolini, M., Torre, A., Visca, D., Villa, S., Kuksa, L., Danila, E., Diktanas, S., Miliauskas, S., Ridaura, R. L., Lopez, F. L. L., Torrico, M. M., Rendon, A., Akkerman, O. W., Piubello, A., Souleymane, M. B., Aizpurua, E., Gonzales, R., Jurado, J., Loban, A., Aguirre, S., De Egea, V., Irala, S., Medina, A., Sequera, G., Sosa, N., Vazquez, F., Manga, S., Villanueva, R., Araujo, D., Duarte, R., Marques, T. S., Grecu, V. I., Socaci, A., Barkanova, O., Bogorodskaya, M., Borisov, S., Mariandyshev, A., Kaluzhenina, A., Stosic, M., Beh, D., Ng, D., Ong, C. W. M., Solovic, I., Dheda, D., Gina, P., Caminero, J. A., Cardoso-Landivar, J., De Souza Galvao, M. L., Dominguez-Castellano, A., Garcia-Garcia, J. -M., Pinargote, I. M., Fernandez, S. Q., Sanchez-Montalva, A., Huguet, E. T., Murguiondo, M. Z., Bruchfeld, J., Bart, P. -A., Mazza-Stalder, J., Tiberi, S., Arrieta, F., Heysell, S., Logsdon, J., Young, L., Department of Physics [Glasgow], University of Strathclyde [Glasgow], Instituto de Fisica Corpuscular (IFIC), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC)-Universitat de València (UV), Laboratoire d'Etude des Mécanismes Cognitifs (EMC), Université Lumière - Lyon 2 (UL2), Added Value Solutions (AVS), Universidade de Santiago de Compostela [Spain] (USC ), Departamento de Ingeniería Térmica y de Fluidos, Avda. Universidad 30, University Medical Center Göttingen (UMG), CHU Amiens-Picardie, Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Réanimation Médicale [CHU Henri Mondor - APHP] (DHU A-TVB), CHU Henri Mondor-Université Paris-Est Créteil, Faculté de Médecine [Créteil] (UPEC-Médecine), Inter-University Centre for Astronomy and Astrophysics [Pune] (IUCAA), Alma Mater Studiorum University of Bologna (UNIBO), Laboratoire des EcoSystèmes et des Sociétés en Montagne (UR LESSEM), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Università degli Studi di Milano = University of Milan (UNIMI), Vilnius University [Vilnius], Instituto de Ciencias Nucleares [Mexico], Universidad Nacional Autónoma de México = National Autonomous University of Mexico (UNAM), Instituto Mexicano del Petróleo (IMP), University of Cadiz, Hospital Universitario Puerta de Hierro-Majadahonda [Madrid, Spain], Bart's and The London School of Medicine and Dentistry, Queen Mary University of London (QMUL), Southwest Research Institute [Boulder] (SwRI), BIOLOGICAL AND AGRICULTURAL ENGINEERING NORTH CAROLINA STATE UNIVERSITY RALEIGH USA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Microbes in Health and Disease (MHD), Université Paris-Est Créteil, Faculté de Médecine [Créteil] (UPEC-Médecine)-CHU Henri Mondor, Università degli Studi di Milano [Milano] (UNIMI), and Universidad Nacional Autónoma de México (UNAM) more...

Subjects
Pulmonary and Respiratory Medicine, Research design, medicine.medical_specialty, Tuberculosis, Coronavirus disease 2019 (COVID-19), [SDV]Life Sciences [q-bio], MEDLINE, Global Health, medicine, Global health, Humans, Multicenter Studies as Topic, Prospective Studies, Intensive care medicine, Prospective cohort study, Tuberculosis, Pulmonary, ComputingMilieux_MISCELLANEOUS, business.industry, Coinfection, COVID-19, Pulmonary, medicine.disease, Infectious Diseases, Research Design, business, Co infection
Abstract

International audience

Published
2021
Full Text
View/download PDF

4. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Author

Elena Sumarokova, Gina Gualano, Evgeny Belilovski, Armine Izadifar, Eva Tabernero, Pierre Bachez, Alessandro Torre, Maria Luiza de Souza-Galvão, François-Xavier Blanc, Claire Andrejak, Mathilde Fréchet Jachym, Denise Rossato Silva, Paolo Scarpellini, Margarita Marín Royo, Dina Visca, Ángel Domínguez-Castellano, Teresa Rodrigo, Antoine Froissart, Damien Le Dû, Giovanni Sotgiu, Antonio Spanevello, Pierre-Alexandre Bart, Simon Tiberi, Miguel Zabaleta Murguiondo, Frédéric Schlemmer, Marina Tadolini, Rosella Centis, Matteo Saporiti, Sergey Borisov, Giovanni Battista Migliori, Vania Giacomet, Delia Goletti, Frédéric Rivière, Ilaria Motta, Samir Dourmane, Soazic Grard, José Cardoso-Landivar, José-María García-García, Jesica Mazza-Stalder, Fabrizio Palmieri, Luigi Codecasa, Catherine W.M. Ong, Adrián Sánchez-Montalvá, Lia D'Ambrosio, Jan-Willem C. Alffenaar, Paul A. Tambyah, Tadolini M., Codecasa L.R., Garcia-Garcia J.-M., Blanc F.-X., Borisov S., Alffenaar J.-W., Andrejak C., Bachez P., Bart P.-A., Belilovski E., Cardoso-Landivar J., Centis R., D'Ambrosio L., De Souza-Galvao M.-L., Dominguez-Castellano A., Dourmane S., Jachym M.F., Froissart A., Giacomet V., Goletti D., Grard S., Gualano G., Izadifar A., Le Du D., Royo M.M., Mazza-Stalder J., Motta I., Min Ong C.W., Palmieri F., Riviere F., Rodrigo T., Silva D.R., Sanchez-Montalva A., Saporiti M., Scarpellini P., Schlemmer F., Spanevello A., Sumarokova E., Tabernero E., Tambyah P.A., Tiberi S., Torre A., Visca D., Murguiondo M.Z., Sotgiu G., Migliori G.B., Centre hospitalier universitaire de Nantes (CHU Nantes), University Medical Center Groningen [Groningen] (UMCG), CHU Amiens-Picardie, Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, CHU Henri Mondor, Centre Hospitalier Intercommunal de Créteil (CHIC), Istituto Nazionale di Malattie Infettive 'Lazzaro Spallanzani' (INMI), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Hôpital Raymond Poincaré [AP-HP], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Maturation des proteines, destinée cellulaire et thérapeutique (PROMTI), Département Biologie des Génomes (DBG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Aristotle University of Thessaloniki, [Tadolini,m] Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. [Codecasa,LR, Saporiti,M] TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy. [García-García,JM, Rodrigo,T]Tuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain. [Blanc,FX] Centre Hospitalier Universitaire, Nantes, France. [Borisov,S, Belilovski,E, Sumarokova,E] Moscow Research and Clinical Center for TB Control, Moscow, Russian Federation. [Alffenaar,JW] The University of Sydney, Sydney Pharmacy School, Sydney, Australia. [Alffenaar,JW] Westmead Hospital, Sydney, Australia. [Alffenaar,JW] Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia. [Andréjak,C] Service de Pneumologie CHU AMIENS PICARDIE, France AND UR Université de Picardie Jules Verne, Amiens, France. [Bachez,P] Service de Pneumologie, Clinique Saint Luc, Bouge, Belgium. [Bart,PA] Dept of Internal Medicine, Lausanne University, Lausanne, Switzerland. [Cardoso-Landivar,J] Servicio Neumología, Vall D´Hebron University Hospital, Barcelona, Spain. [Centis,R] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy. [D'Ambrosio,L] Public Health Consulting Group, Lugano, Switzerland. [Dominguez-Castellano,A] Servicio de Enfermedades Infecciosas y Microbiología, Hospital Virgen Macarena, Sevilla, Spain. [Dourmane,S] Service de Pneumologie, Groupe hospitalier sud île de France (GHSIF), Melun, France. [Fréchet Jachym,M, Le Du,D] Centre Hospitalier de Bligny, Briis Sous Forges, France. [Froissart,A] Service de Médecine interne, CHI de Créteil, Créteil, France. [Giacomet,V]20Pediatric Infectious Diseases Unit, Dept of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy. [Goletti,D] Translational Research Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Grard,S] Centre de Lutte Antituberculeuse (CLAT 38), Grenoble, France. [Gualano,G, Palmieri,F] Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Izadifar,A] Hôpital Européen de Paris La Roseraie, Aubervilliers, France. [Marín Royo,M] Servicio Neumología, Hospital General Universitario de Castellón, Castelló, Spain. [Mazza-Stalder,J] Pulmonary Division, Lausanne University Hospital CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Motta,I] Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italia. [Ong,CWM, Tambyah,PA] Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [Ong,CWM, Tambyah,PA] Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore. [Rivière,F] Hôpital d'Instruction des Armées (HIA) Percy, Clamart, France. [Silva,DR] Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS, Porto Alegre, Brazil. [Sánchez-Montalvá,A]Infectious Diseases Dept, International Health and Tuberculosis Unit, Vall d'Hebron University Hospital, Barcelona, Spain. [Sánchez-Montalvá,A] Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain. [Sánchez-Montalvá,A] Grupo de Estudio de Infecciones por Micobacterias (GEIM), Spanish Society of Infectious Diseases (SEIMC), Spain. [Scarpellini,P] Unit of Infectious Diseases, Università Vita e Salute, San Raffaele Hospital, Milan, Italy. [Schlemmer,F] Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France. [Spanevello,A, Visca,D] Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy. [Spanevello,A, Visca,D] Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Italy. [Tabernero,E] Servicio Neumología, Hospital de Cruces, Bilbao, Spain. [Tiberi,S] Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. [Tiberi,S] Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. [Torre,A] Dept of Infectious Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. [Zabaleta Murguiondo,M] Servicio Neumología Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Sotgiu,G] Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. [Migliori,GB] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy., and CHU Henri Mondor [Créteil] more...

Subjects
Male, Pediatrics, Adult, Aged, Antitubercular Agents/therapeutic use, Antiviral Agents/therapeutic use, Azithromycin/therapeutic use, Betacoronavirus, Clinical Laboratory Techniques, Cohort Studies, Coinfection, Coronavirus Infections/complications, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Drug Combinations, Emigrants and Immigrants, Female, Humans, Hydroxychloroquine/therapeutic use, Lopinavir/therapeutic use, Lung/diagnostic imaging, Middle Aged, Mortality, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Ritonavir/therapeutic use, Tomography, X-Ray Computed, Tuberculosis/complications, Tuberculosis/diagnosis, Tuberculosis/drug therapy, Tuberculosis, Pulmonary/complications, Tuberculosis, Pulmonary/diagnosis, Tuberculosis, Pulmonary/drug therapy, [SDV]Life Sciences [q-bio], viruses, Antitubercular Agents, Azithromycin, Clinical Laboratory Technique, Lopinavir, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Sequelae, Antitubercular Agent, 0302 clinical medicine, COVID-19 Testing, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography [Medical Subject Headings], Drug Combination, 030212 general & internal medicine, Viral, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques [Medical Subject Headings], Lung, Tomography, ComputingMilieux_MISCELLANEOUS, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Vital Statistics::Mortality [Medical Subject Headings], virus diseases, Pulmonary, respiratory system, X-Ray Computed, Impactos en la salud, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography [Medical Subject Headings], Cohort, Coronavirus Infections, medicine.drug, Cohort study, Human, Hydroxychloroquine, Impacts on health, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Tuberculosis, Tuberculosi, Infecciones por coronavirus, Estudios de cohortes, Pneumonia, Viral, Antiviral Agents, Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Mycobacterium Infections::Tuberculosis [Medical Subject Headings], 03 medical and health sciences, Tuberculosis diagnosis, medicine, Research Letter, Tuberculosis, Pulmonary, Secuelas, Ritonavir, Antiviral Agent, Pandemia, Betacoronaviru, Pandemic, business.industry, Coronavirus Infection, SARS-CoV-2, COVID-19, Emigrants and Immigrant, Pneumonia, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents::Antitubercular Agents [Medical Subject Headings], medicine.disease, Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [Medical Subject Headings], COVID-19 Drug Treatment, Coronavirus, 030228 respiratory system, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Cohort Studie, business
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5]. more...

Published
2020
Full Text
View/download PDF

5. Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

Author

Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, Ezz W, Cho JG, Denholm J, Skrahina A, Solodovnikova V, Arbex MA, Alves T, Rabahi MF, Pereira GR, Sales R, Silva DR, Saffie MM, Salinas NE, Miranda RC, Cisterna C, Concha C, Fernandez I, Villalón C, Vera CG, Tapia PG, Cancino V, Carbonell M, Cruz A, Muñoz E, Muñoz C, Navarro I, Pizarro R, Cristina Sánchez GP, Vergara Riquelme MS, Vilca E, Soto A, Flores X, Garavagno A, Bahamondes MH, Merino LM, Pradenas AM, Revillot ME, Rodriguez P, Salinas AS, Taiba C, Valdés JF, Subiabre JN, Ortega C, Palma S, Castillo PP, Pinto M, Bidegain FR, Venegas M, Yucra E, Li Y, Cruz A, Guelvez B, Victoria Plaza R, Tello Hoyos KY, Cardoso-Landivar J, Van Den Boom M, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Gupta N, Ish P, Mishra G, Patel JM, Singla R, Udwadia ZF, Alladio F, Angeli F, Calcagno A, Centis R, Codecasa LR, De Lauretis A, Esposito SMR, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Matteelli A, Migliori GB, Motta I, Palmieri F, Pontali E, Prestileo T, Riccardi N, Saderi L, Saporiti M, Sotgiu G, Spanevello A, Stochino C, Tadolini M, Torre A, Villa S, Visca D, Kurhasani X, Furjani M, Rasheed N, Danila E, Diktanas S, Ridaura RL, Luna López FL, Torrico MM, Rendon A, Akkerman OW, Chizaram O, Al-Abri S, Alyaquobi F, Althohli K, Aguirre S, Teixeira RC, De Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Llanos-Tejada FK, Manga S, Villanueva-Villegas R, Araujo D, Sales Marques RD, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Vukicevic TA, Stosic M, Beh D, Ng D, Ong CWM, Solovic I, Dheda K, Gina P, Caminero JA, De Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bart PA, Mazza-Stalder J, D'Ambrosio L, Kamolwat P, Bakko F, Barnacle J, Bird S, Brown A, Chandran S, Killington K, Man K, Papineni P, Ritchie F, Tiberi S, Utjesanovic N, Zenner D, Hearn JL, Heysell S, and Young L more...

Subjects
Humans, Male, Risk Factors, Retrospective Studies, COVID-19 complications, HIV Infections complications, Coinfection, Tuberculosis, Miliary
Abstract

Background: Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19., Methods: We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both., Results: Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44-18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53)., Conclusions: In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes., Competing Interests: Conflict of interest: The authors have no potential conflicts of interest to disclose., (Copyright ©The authors 2023.) more...

Published
2023
Full Text
View/download PDF

7. TB and COVID-19 co-infection: rationale and aims of a global study.

Author

Casco N, Jorge AL, Palmero D, Alffenaar JW, Fox G, Ezz W, Cho JG, Skrahina A, Solodovnikova V, Bachez P, Arbex MA, Galvão T, Rabahi M, Pereira GR, Sales R, Silva DR, Saffie MM, Miranda RC, Cancino V, Carbonell M, Cisterna C, Concha C, Cruz A, Salinas NE, Revillot ME, Farias J, Fernandez I, Flores X, Gallegos P, Garavagno A, Guajardo C, Bahamondes MH, Merino LM, Muñoz E, Muñoz C, Navarro I, Navarro J, Ortega C, Palma S, Pardenas AM, Pereira G, Castillo PP, Pinto M, Pizarro R, Rivas F, Rodriguez P, Sánchez C, Serrano A, Soto A, Taiba C, Venegas M, Vergara MS, Vilca E, Villalon C, Yucra E, Li Y, Cruz A, Guelvez B, Plaza R, Tello K, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Gupta N, Ish P, Mishra G, Sharma S, Singla R, Udwadia ZF, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Alladio F, Calcagno A, Centis R, Codecasa LR, D Ambrosio L, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Kuksa L, Danila E, Diktanas S, Miliauskas S, Ridaura RL, López F, Torrico MM, Rendon A, Akkerman OW, Piubello A, Souleymane MB, Aizpurua E, Gonzales R, Jurado J, Loban A, Aguirre S, de Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Manga S, Villanueva R, Araujo D, Duarte R, Marques TS, Grecu VI, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Stosic M, Beh D, Ng D, Ong C, Solovic I, Dheda D, Gina P, Caminero JA, Cardoso-Landivar J, de Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bruchfeld J, Bart PA, Mazza-Stalder J, Tiberi S, Arrieta F, Heysell S, Logsdon J, and Young L more...

Subjects
Coinfection, Global Health, Humans, Multicenter Studies as Topic, Prospective Studies, Research Design, COVID-19 complications, Tuberculosis, Pulmonary complications
Published
2021
Full Text
View/download PDF

8. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.

Author

Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, and Migliori GB more...

Subjects
Adult, Aged, Antitubercular Agents therapeutic use, Antiviral Agents therapeutic use, Azithromycin therapeutic use, Betacoronavirus, COVID-19, COVID-19 Testing, Clinical Laboratory Techniques, Cohort Studies, Coinfection, Coronavirus Infections diagnosis, Coronavirus Infections drug therapy, Drug Combinations, Emigrants and Immigrants, Female, Humans, Hydroxychloroquine therapeutic use, Lopinavir therapeutic use, Lung diagnostic imaging, Male, Middle Aged, Mortality, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral drug therapy, Ritonavir therapeutic use, SARS-CoV-2, Tomography, X-Ray Computed, Tuberculosis complications, Tuberculosis diagnosis, Tuberculosis drug therapy, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary drug therapy, COVID-19 Drug Treatment, Coronavirus Infections complications, Pneumonia, Viral complications, Tuberculosis, Pulmonary complications
Abstract

Competing Interests: Conflict of interest: M. Tadolini has nothing to disclose. Conflict of interest: L.R. Codecasa has nothing to disclose. Conflict of interest: J-M. García-García has nothing to disclose. Conflict of interest: F-X. Blanc has nothing to disclose. Conflict of interest: S. Borisov has nothing to disclose. Conflict of interest: J-W. Alffenaar has nothing to disclose. Conflict of interest: C. Andréjak has nothing to disclose. Conflict of interest: P. Bachez has nothing to disclose. Conflict of interest: P-A. Bart has nothing to disclose. Conflict of interest: E. Belilovski has nothing to disclose. Conflict of interest: J. Cardoso-Landivar has nothing to disclose. Conflict of interest: R. Centis has nothing to disclose. Conflict of interest: L. D'Ambrosio has nothing to disclose. Conflict of interest: M-L. De Souza-Galvão has nothing to disclose. Conflict of interest: A. Dominguez-Castellano has nothing to disclose. Conflict of interest: S. Dourmane has nothing to disclose. Conflict of interest: M. Fréchet Jachym has nothing to disclose. Conflict of interest: A. Froissart has nothing to disclose. Conflict of interest: V. Giacomet has nothing to disclose. Conflict of interest: D. Goletti has nothing to disclose. Conflict of interest: S. Grard has nothing to disclose. Conflict of interest: G. Gualano has nothing to disclose. Conflict of interest: A. Izadifar has nothing to disclose. Conflict of interest: D. Le Du has nothing to disclose. Conflict of interest: M. Marín Royo has nothing to disclose. Conflict of interest: J. Mazza-Stalder has nothing to disclose. Conflict of interest: I. Motta has nothing to disclose. Conflict of interest: C.W.M. Ong has nothing to disclose. Conflict of interest: F. Palmieri has nothing to disclose. Conflict of interest: F. Rivière has nothing to disclose. Conflict of interest: T. Rodrigo has nothing to disclose. Conflict of interest: D.R. Silva has nothing to disclose. Conflict of interest: A. Sánchez-Montalvá has nothing to disclose. Conflict of interest: M. Saporiti has nothing to disclose. Conflict of interest: P. Scarpellini has nothing to disclose. Conflict of interest: F. Schlemmer has nothing to disclose. Conflict of interest: A. Spanevello has nothing to disclose. Conflict of interest: E. Sumarokova has nothing to disclose. Conflict of interest: E. Tabernero has nothing to disclose. Conflict of interest: P.A. Tambyah has nothing to disclose. Conflict of interest: S. Tiberi has nothing to disclose. Conflict of interest: A. Torre has nothing to disclose. Conflict of interest: D. Visca has nothing to disclose. Conflict of interest: M. Zabaleta Murguiondo has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: G.B. Migliori has nothing to disclose. more...

Published
2020
Full Text
View/download PDF